Patent · US Active

BTLA agonist antibodies and uses thereof

US11396545B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Shane Krummen Atwell · Carlsbad, US
Andrew Charles Vendel · San Diego, US
Victor H. Obungu · Fishers, US

Key dates

Filing date	Feb 17, 2020
Grant date	Jul 26, 2022
Priority date	—
Expiry date	Jan 22, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.